A rare entity of Primary Ewing sarcoma in kidney

BMC Surg. 2020 Nov 11;20(1):280. doi: 10.1186/s12893-020-00948-9.

Abstract

Background: Ewing sarcoma (ES) or primitive neuroectodermal tumors (PNET) represents a spectrum of poorly differentiated and aggressive malignancies. It rarely arises from the kidney and accounts for less than 1% of renal mass. Given the uncharacteristic clinical symptoms and imaging features, renal Ewing sarcoma (RES) is often diagnosed by postoperative pathology.

Case presentation: Herein, we depicted a case of RES, which was administrated in our institution by chief complaints of intermittent left plank pain and palpable abdominal mass. We demonstrated the aggressive behavior of this renal malignancy and summarized its therapeutic modalities and outcomes.

Conclusion: The diagnosis of RES relies on integrated analysis including histomorphology, immunohistochemical staining and confirmation of molecular-genetic testing. Despite the surgery and adjuvant therapy, optimized and potent therapeutic regimes are still urgently needed to improve the poor prognosis of RES.

Keywords: Chemotherapy; Nephrectomy; Primitive neuroectodermal tumor (PNET); Renal ewing sarcoma (RES).

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Imaging, Three-Dimensional
  • Kidney / diagnostic imaging
  • Kidney / surgery
  • Kidney Neoplasms* / diagnostic imaging
  • Kidney Neoplasms* / drug therapy
  • Kidney Neoplasms* / pathology
  • Kidney Neoplasms* / surgery
  • Nephrectomy
  • Neuroectodermal Tumors, Primitive, Peripheral* / diagnostic imaging
  • Neuroectodermal Tumors, Primitive, Peripheral* / drug therapy
  • Neuroectodermal Tumors, Primitive, Peripheral* / pathology
  • Neuroectodermal Tumors, Primitive, Peripheral* / surgery
  • Positron Emission Tomography Computed Tomography
  • Sarcoma, Ewing* / diagnostic imaging
  • Sarcoma, Ewing* / drug therapy
  • Sarcoma, Ewing* / pathology
  • Sarcoma, Ewing* / surgery

Substances

  • Antineoplastic Agents